Not-for-profit research and development can address deadly market failure for neglected patients, paper shows

Berlin, Germany – 30 October 2019

15 years of an ‘experiment in innovation’ to discover and develop affordable new treatments in the public interest
In its first 15 years, DNDi has proven that not-for-profit R&D can deliver effective and affordable new treatments to help fill the drug development pipeline for neglected diseases, an area that was suffering from a deadly lack of attention when the organization was created in 2003, according to a new report released today at the two-day DNDi & Founders’ Symposium in Berlin, Germany.

Kempen Saringan Hepatitis C Seluruh Negara Anjuran Kementerian Kesihatan Malaysia

Kuala Lumpur – 17 Julai 2019

Kempen disokong oleh Drugs for Neglected Diseases initiative (DNDi) dan Foundation for Innovative New Diagnostics (FIND), bertujuan untuk mengesan pesakit yang menghidap HCV, iaitu sejenis penyakit yang senyap namun ianya boleh dirawat secara berkesan

Foundation for Innovative New Diagnostics’ (FIND) danDrugs for Neglected Diseases initiative’ (DNDi) sedang bekerjasama dengan Kementerian Kesihatan Malaysia (KKM) bagi melancarkan inisiatif terbesar di seluruh negara dalam usaha penyaringan virus hepatitis C (HCV).

马来西亚卫生部发起全国性C型肝炎检验活动

(吉隆坡17日讯)

在“被忽视疾病药物研发倡议组织”(DNDi)和创新诊断基金会(FIND)的支持下,该活动在为这种无声但可治愈的疾病寻找“遗漏的数百万人”

创新诊断基金会(FIND)和被忽视疾病药物倡议组织(DNDi)正与马来西亚卫生部(MOH)合作,推出我国有史以来规模最大的C型肝炎病毒筛查计划。

การรณรงค์คัดกรองไวรัสตับอักเสบซีทั่วประเทศ โดยกระทรวงสาธารณสุขมาเลเซีย

กัวลาลัมเปอร์ – 17 กรกฎาคม 2562

สนับสนุนโดยองค์กรยารักษาโรคที่ถูกละเลยและมูลนิธิเพื่อการวินิจฉัยเชิงนวัตกรรมใหม่ การรณรงค์เพื่อค้นหา “ผู้สูญหายนับล้าน” สำหรับภัยเงียบจากโรคที่รักษาได้

มูลนิธิเพื่อการวินิจฉัยเชิงนวัตกรรมใหม่ (The Foundation for Innovative New Diagnostics -FIND) และองค์กรยาเพื่อรักษาโรคที่ถูกละเลย (Drugs for Neglected Diseases initiative – DNDi) ร่วมกับกระทรวงสาธารณสุขประเทศมาเลเซีย (MOH) เพื่อเปิดตัวโครงการคัดกรองไวรัสตับอักเสบซี (HCV) ที่ใหญ่ที่สุดในประเทศ

Nationwide hepatitis C screening campaign initiated by the Malaysian Ministry of Health

Kuala Lumpur – 17 July 2019
Supported by Drugs for Neglected Diseases initiative & Foundation for Innovative New Diagnostics, campaign seeks to find the “missing millions” for this silent but curable disease
FIND and DNDi are partnering with the Ministry of Health in Malaysia to launch the country’s biggest-ever screening initiative for the hepatitis C virus.

TICAD7

28-30 August 2019
Yokohama, Japan

  • Monique Wasunna, Director DNDi Africa – symposium on NTDs in Africa and partnerships with Japan

DNDi and Atomwise collaborate to advance drug development using AI for neglected diseases

Geneva, Switzerland and San Francisco, USA – 16 April 2019
Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development
Atomwise, Inc., a biotech company using artificial intelligence (AI) for drug discovery, and DNDi, a not-for-profit research and development organization working to deliver new treatments for neglected diseases, today announced that promising drug-like compounds have been discovered in a programme to develop first-in-class treatments for Chagas disease. The research collaboration is part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards programme.

Chagas disease: the time is now to end 110 years of neglect

Rio de Janeiro – 11 April 2019
The people affected by Chagas disease will claim this 14th of April as World Chagas Day in the hope of increasing global awareness, building on the progress already made against this disease, which has been neglected for more than a century
The International Federation of Associations of People Affected by Chagas disease (FINDECHAGAS) has launched an online petition through the platform change.org in support of the official declaration of April 14th as their World Day. This proposal will be tabled at the 72nd World Health Assembly, to be held in Geneva at the end of May 2019. The particular date has been chosen because on that same day, 110 years ago, the Brazilian doctor Carlos Chagas confirmed the first case of the disease in a child, called Berenice Soares.

GARDP set up as independent legal entity

Geneva, Switzerland – 2 April 2019
Continued close collaboration with founding partners will strengthen GARDP’s efforts to address AMR
GARDP is now an independent legal entity following a successful three-year incubation, hosted by DNDi. During this time, GARDP has already begun working with partners to develop antibiotics to tackle drug-resistant infections which pose a threat to global health and development, including the achievement of the Sustainable Development Goals.